All News

Medicaid prescription reimbursement rates by state --2003

NACDS and Express Scripts recently announced they are jointly seeking endorsement of a national Medicare discount card from CMS.

NCPA objects to cuts in payment for Medicare Part B drugs

States are up in the air about their discount card programs following the passage of the Medicare drug benefit legislation, which has a provision for an Rx card program

All eyes are glued to ACPE to see whether it will require national standards in tech education

More state pharmacy boards enacted various regulations governing pharmacy technicians last year, according to the 2003-2004 NABP Survey of Pharmacy Law.

Some experts believe that the pendulum has swung too far--not all drug errors should be blamed on systems

Archives of Neurology article offers recommendations for pharmacological management of neuropathic pain.

USP Drug Safety Review

Get set for new medication management standards from JCAHO

This installment discusses new frequently answered questions the government has just released

No numbers, no prescriptions

USP gives fourth annual report on its MEDMARX findings relative to drug errors reported by hospitals related to JCAHO's patient safety goals

Clinicians can now treat patients with bipolar depression using the first drug approved in the U.S. for this indication. The FDA recently approved olanzapine/fluoxetine (Symbyax, Eli Lilly) for the treatment of depressive episodes associated with bipolar disorder. Symbyax is currently available in pharmacies.

How hospitals are implementing damage control in the wake of a wave of drug errors

Following in the footsteps of Walgreens, CVS announced that it will not participate in future health plan contracts requiring refill scripts to be filled by mail order pharmacies.

More clients of pharmacy benefit managers are auditing their performance

stockchecker on incontinence

The main cause of patient not taking their medications is a breakdown in communications, according to a study by Cutting Edge Information.

Pharmacists and technicians are needed to staff 10 regionally based disaster response teams pharmacy organizations agreed to create to assist the Federal Emergency Management Agency.

ACPE holds last hearing to solicit comments on whether uniform, national standards should be set up for the training of pharmacy technicians

At NCPIE meeting, FDA discusses how it plans to improve prescription information to consumers

Medicine Shoppe acquires Medicap Pharmacies

Confusion between Keppra and Kaletra is fanned by their sound-alike, look-alike names

Pharmacists from all walks weigh in on the impact of this landmark legislation

Several community pharmacy groups will be seeking Medicare's approval of a discount drug card program they are developing to benefit enrollees and help pharmacies stay solvent.

ASHP recommends taking precautions with 30 high-risk drugs to thwart counterfeiting

Clinicians will soon be able to offer another treatment option to men with prostate cancer who have not responded to hormonal therapy. The FDA recently approved abarelix (Plenaxis, Praecis Pharmaceuticals) for the palliative treatment of men with advanced symptomatic prostate cancer in whom luteinizing hormone releasing hormone (LHRH) agonist therapy is inappropriate and who refuse surgical castration, and have risk of neurological compromise due to metastases; ureteral or bladder outlet obstruction due to local encroachment or metastatic disease; and/or severe bone pain from skeletal metastases persisting on narcotic analgesia. The drug will be available sometime during the first quarter of 2004.

Clinicians will soon be able to offer men with erectile dysfunction (ED) a new drug that researchers believe has several advantages over currently available therapies. The FDA recently approved tadalafil (Cialis, Eli Lilly) for the treatment of ED. Tadalafil is currently available in pharmacies.